GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Financiere de Tubize SA (XBRU:TUB) » Definitions » 3-Year FCF Growth Rate

Financiere de Tubize (XBRU:TUB) 3-Year FCF Growth Rate : 0.70% (As of Dec. 2023)


View and export this data going back to 1985. Start your Free Trial

What is Financiere de Tubize 3-Year FCF Growth Rate?

Financiere de Tubize's Free Cash Flow per Share for the six months ended in Dec. 2023 was €-0.03.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was 0.70% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was -13.50% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was -13.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

During the past 13 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of Financiere de Tubize was 64.40% per year. The lowest was -33.00% per year. And the median was -1.00% per year.


Competitive Comparison of Financiere de Tubize's 3-Year FCF Growth Rate

For the Biotechnology subindustry, Financiere de Tubize's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Financiere de Tubize's 3-Year FCF Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Financiere de Tubize's 3-Year FCF Growth Rate distribution charts can be found below:

* The bar in red indicates where Financiere de Tubize's 3-Year FCF Growth Rate falls into.



Financiere de Tubize 3-Year FCF Growth Rate Calculation

This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.


Financiere de Tubize  (XBRU:TUB) 3-Year FCF Growth Rate Explanation

Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.


Financiere de Tubize 3-Year FCF Growth Rate Related Terms

Thank you for viewing the detailed overview of Financiere de Tubize's 3-Year FCF Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Financiere de Tubize (XBRU:TUB) Business Description

Traded in Other Exchanges
Address
Allée de la Recherche, 60, Brussels, BEL, 1070
Financiere de Tubize SA is a holding company that owns a stake in UCB, a biopharmaceutical company. UCB is a global biotechnology company that develops treatments for conditions related to neurology and immunology. UCB generates the vast majority of its revenue in the United States, followed by Europe and other international markets. Most of its sales revenue is derived from its neurology products, followed by its immunology products. The company's strategy focuses on leveraging scientific advances and skills in areas such as genetics, biomarkers, and human biology.

Financiere de Tubize (XBRU:TUB) Headlines

No Headlines